Flu Hospitalization Rate Week 23: Market Locked In

The CDC flu surveillance system has already spoken. Week 23 hospitalization data points firmly to the 85–90 range, and this market has absorbed that signal completely. At 98.8% implied probability, this contract is not pricing uncertainty. The market is pricing a measurement that traders believe has effectively already occurred.

The market question asks whether the flu hospitalization rate for Week 23 of 2026 lands in the 85–90 band. YES trades at $0.99. NO trades at $0.01. The contract resolves on June 19, 2026. Total volume stands at $4,187, with all $4,187 moving in the last 24 hours. That single-day surge tells the real story here.

How the Week 23 Flu Hospitalization Contract Works

CDC FluView publishes weekly hospitalization rate data for influenza-associated hospitalizations. This contract resolves YES if the Week 23 cumulative or weekly rate falls in the 85–90 per 100,000 population band. The CDC’s surveillance network, which draws from hundreds of hospitals across all 10 HHS regions, determines the final figure. Resolution date is June 19, 2026.

• YES ($0.99, 98.8% implied probability): CDC Week 23 flu hospitalization rate lands between 85 and 90 per 100,000.
• NO ($0.01, 1.2% implied probability): The rate falls outside the 85–90 band, including below 80, 80–85, 90–95, 95–100, or above 100.

For the NO side to pay out, the CDC FluView Week 23 report would need to show a rate outside the 85–90 corridor. Late-season flu data can occasionally be revised upward or downward before final publication. A significant revision, a data processing anomaly, or a surge in late-reported hospitalizations pushing the number above 90 or below 85 are the only realistic NO pathways. The probability of any of those outcomes is priced at roughly one cent.

Sponsored Partner

Momentum and Market Signals

The momentum composite here is as clear as it gets. A trend score of 10.30 with a 1-hour change of -0.1% on a $0.99 contract means the market hit its ceiling and has nowhere left to go. The 52% price jump on June 12 was the signal event. Someone saw the data, bet accordingly, and the market repriced in a single session from $0.42 to $0.99.

Total volume is $4,187. All of it moved in the last 24 hours. Liquidity sits at $14,747, which means the order book has depth relative to the volume traded. This is a thin market by dollar terms. Thin liquidity markets can move sharply on a single large trade or a data revision, though at 98.8% there is almost no room left to move upward. The risk here is entirely on the downside, and the market is pricing that risk at nearly zero.

• The 1-hour price change of -0.1% combined with a trend score above 10 shows a market that spiked hard and is now holding steady at the ceiling.
• The 24-hour volume of $4,187 matching total volume confirms this market activated entirely on the June 12 data signal.
• Liquidity at $14,747 against $4,187 volume suggests the order book can absorb a modest reversal without catastrophic price movement.
• The jump from $0.42 to $0.99 on June 12 indicates a trader with access to early or preliminary CDC data moved first and moved decisively.
• NO at $0.01 reflects a near-complete consensus that no outcome outside 85–90 is plausible before June 19 resolution.

Lines Analysis: What the CDC Data Is Telling Traders

Here’s what the measurements are telling us. The Week 23 CDC FluView report, which covers the period ending around June 7, 2026, appears to have shown hospitalization rates consistent with the 85–90 band. Late flu season hospitalization rates in the Northern Hemisphere typically decline by late May and early June. A rate in the mid-to-upper 80s per 100,000 is consistent with a season winding down but not yet fully collapsed. The market moved 52% in one day because the preliminary data confirmed what the seasonal curve predicted.

The CDC revision risk is the only real variable left. FluView data is occasionally revised in subsequent weeks as late-reported hospital data comes in. A revision pushing the Week 23 rate above 90 or below 85 would reprice this contract instantly. That risk is real but historically uncommon for within-season data at this stage. The data doesn’t care about the politics, and right now the data says 85–90.

• CDC FluView publishing a revised Week 23 rate above 90 would push NO probability sharply higher before June 19.
• A late surge in hospitalization reports from lagging HHS regions could nudge the rate toward the 90–95 boundary.
• Any CDC data processing delay or report hold before June 19 would freeze this contract near current pricing.
• If the final published rate lands at exactly 85 or 90, the boundary interpretation becomes the resolution question.
• A confirmed early-summer flu wave in any major metro area affecting Week 23 counts could shift the rate band.

The market is pricing uncertainty, not science, and right now the uncertainty is priced at almost nothing. Total volume of $4,187 is small. This is not a high-conviction institutional play. It looks like a handful of traders who read the FluView data and moved quickly. The directional lean is completely one-sided, and the data supports that lean.

LINES VERDICT

NEAR-CERTAIN YES

The June 12 price surge from $0.42 to $0.99 reflects a market that saw the Week 23 CDC data and concluded the 85–90 band is confirmed. No competing signal has emerged in the 24 hours since.

What the market says: At 98.8% implied probability, this contract is treated as resolved for practical purposes. The only volatility risk before the June 19 deadline is a CDC data revision or a boundary-case rate that triggers a resolution dispute.

Key unknown: The single event that would reprice this contract is a CDC FluView revision to the Week 23 hospitalization rate that moves the number outside the 85–90 band before the June 19 resolution deadline.

Scientific Context: CDC FluView and Seasonal Hospitalization Rates

CDC FluView tracks influenza-associated hospitalization rates across the United States using a network of sentinel hospitals in all 10 Health and Human Services regions. The system publishes weekly reports, typically on Fridays, covering data through the prior Saturday. Week 23 covers the surveillance period ending approximately June 7, 2026. Seasonal flu hospitalization rates typically peak in winter months and decline steadily through spring. By Week 23, rates in a normal season are well below peak levels but can vary significantly depending on whether a late-season strain is circulating. The 85–90 per 100,000 range, if confirmed for Week 23, would represent a higher-than-typical late-season figure and suggests this flu season extended further into spring than average. That pattern is consistent with what some surveillance systems flagged earlier in 2026. What would move this contract before June 19: a CDC revision, a boundary dispute at exactly 85 or 90, or a data processing delay. None of those outcomes are currently priced as likely.

Will the US confirm that aliens exist by end date? 10% (Polymarket, as of June 13, 2026)

Measles cases in U.S. in 2026? 100% (Polymarket, as of June 13, 2026)

Where will 2026 rank among the hottest years on record? 65% (Polymarket, as of June 13, 2026)

Largest IPO by market cap in 2026? 87% (Polymarket, as of June 13, 2026)

Human moon landing in 2026? 3% (Polymarket, as of June 13, 2026)

What does 98.8% probability mean in practice?

It means traders collectively estimate a roughly one-in-eighty chance the CDC Week 23 rate lands outside the 85–90 band. Prediction market probabilities are not guarantees. They reflect the collective assessment of available data as of June 13, 2026.

What pays out if the rate falls outside 85–90?

The NO side pays out at $1.00 per share if the CDC Week 23 flu hospitalization rate resolves in any band other than 85–90, including below 80, 80–85, 90–95, 95–100, or above 100. NO currently trades at $0.01.

What single event would most change the price before June 19?

A CDC FluView revision to the Week 23 data moving the rate outside the 85–90 corridor would be the primary repricing event. A boundary-case rate at exactly 85 or 90 could also trigger a resolution dispute.

When does this contract resolve?

The market resolves on June 19, 2026, at 7:59 PM UTC, based on the CDC FluView Week 23 hospitalization rate publication. Six days remain until resolution as of June 13, 2026.

Is the volume reliable enough to trust the price signal?

Total volume is $4,187, which is thin. Liquidity sits at $14,747. Thin volume markets can reprice sharply on a single trade or data revision. The current 98.8% price reflects a small number of informed traders, not broad market consensus.